MESONEPHRIC GYNECOLOGIC CANCER

Clinical trials for MESONEPHRIC GYNECOLOGIC CANCER explained in plain language.

Never miss a new study

Get alerted when new MESONEPHRIC GYNECOLOGIC CANCER trials appear

Sign up with your email to follow new studies for MESONEPHRIC GYNECOLOGIC CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New drug combo tested for Tough-to-Treat gynecologic cancer

Disease control Recruiting now

This study is testing whether a combination of two oral drugs, avutometinib and defactinib, can help control advanced or recurrent mesonephric gynecologic cancer. It will enroll about 40 adult women whose cancer has persisted or returned after prior treatment. The main goal is to…

Matched conditions: MESONEPHRIC GYNECOLOGIC CANCER

Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control

Last updated Apr 02, 2026 03:40 UTC

MESONEPHRIC GYNECOLOGIC CANCER

Get alerted when new MESONEPHRIC GYNECOLOGIC CANCER trials appear

New drug combo tested for Tough-to-Treat gynecologic cancer